OBJECTIVES The aim of this study was to describe current practice regarding completeness of revascularization in patients with multivessel disease undergoing percutaneous coronary intervention (PCI) and to investigate the association of incomplete revascularization (IR) with death, repeat revascularization, and myocardial infarction (MI) in a large nationwide registry.
of all significant stenoses, however, necessitates a more complex intervention with a potentially higher risk for complications, increases radiation exposure and use of contrast agent, and has been associated with worse prognosis for patients with STEMI in some observational studies (9, 10) , whereas others have suggested the opposite (11) . A recent randomized trial demonstrated a substantially reduced risk of adverse cardiovascular events with multivessel PCI (12) . For patients presenting with STEMI, PCI of nonculprit vessels in the acute setting is generally discouraged in guidelines, except for patients presenting with cardiogenic shock, persistent ischemia, or in patients where electrocardiogram localization of the infarction is ambiguous and leads to difficulties in identifying the culprit lesion (13, 17, 18) .
Because previous observational studies and small randomized trials have yielded conflicting evidence as to which strategy is superior, the evidence base for these recommendations is rather weak.
Therefore, the aim of this study was to describe current practice regarding completeness of revascularization in a large and unselected national cohort of patients with multivessel disease undergoing PCI, and to investigate the association of IR with death, repeat revascularization, and myocardial infarction (MI).
METHODS
PATIENTS. This was an observational study of prospectively collected data from the SWEDEHEART (Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies) and the Swedish national health data registries. Hambraeus et al.
Outcome of Incomplete Revascularization After PCI Hambraeus et al. Table 1) .
More than 1 procedure was performed in 711 cases before discharge from hospital.
In-hospital death occurred in 571 patients: 475 in the IR group and 96 in the CR group.
IR was performed in the majority of patients with 3-vessel disease (6,302 of 7,524; 84%), presenting with STEMI (6,143 of 7,673; 80%), and presenting after office hours (4,961 of 6,570; 76%). IR patients were more often treated with DES. FFR measurements were used in 3.0% of the IR group and 6.1% of the CR group ( Table 2 ).
Adherence to current secondary prevention guidelines regarding medication was high in both IR and CR groups. Prescription of long-acting nitroglycerin at discharge was more common in the IR group ( Table 3) . When data was reanalyzed using propensity score matching, consistent results were found with a similar difference in risk of death, MI, or repeat revascularization between the IR and CR groups: Table 5) .
When we prolonged the time interval to 2, 4, or 8
weeks to determine revascularization status of the study patients, the magnitude of effect size for the combined endpoint was similar (Online Tables 2S to 4S ).
However, when we analyzed death up to 1 year only in patients surviving to discharge, the differences in HR between the IR and CR groups did not remain in all subgroups ( Table 6 ). The effect of performing CR on mortality, repeat revascularization, and MI has been investigated only in a few small prospective randomized trials. In a single-center study, 219 patients without ongoing MI were randomized to PCI of the culprit vessel only Values are n (%).
DISCUSSION
CABG ¼ coronary artery bypass graft surgery; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention. Tables 1 and 2 . Values are hazard ratio (HR) (95% confidence interval). Repeat revascularization is analyzed as a time-dependent variable. Only patients surviving to discharge from hospital are included in this analysis (n ¼ 22,771).
Abbreviations as in Tables 1, 2 , and 4.
been technically addressable by PCI. Presence of CTO in a noninfarct-related artery has been demonstrated to be an indicator of mortality (1), whereas successful CTO PCI has been associated with lower mortality in patients in stable condition and a small study with STEMI patients (34, 35) .
Third, the use of FFR measurement as an additional method to evaluate which stenoses were functionally significant, as opposed to relying on anatomical estimation, was used in only a minority of patients. Increased use of FFR measurement in non-STEMI ACS patients and patients in stable condition has the potential to reclassify patients regarding number of diseased vessels and has been shown to improve outcome (36).
Because our study is observational, the question of whether the higher event rates in incompletely revascularized patients can be lowered with a treatment strategy aiming at full revascularization still remains unclear and cannot be answered in a registry study. WHAT IS NEW? Our observational study showed that IR at the time of hospital discharge was associated with a high risk of 1-year mortality, MI, or repeat revascularization.
CONCLUSIONS
WHAT IS NEXT? Whether this high risk can be reduced by a strategy of CR needs to be further investigated in a randomized trial.
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